A. Stirling

2.1k citations

14 papers · 1.5k indexed · 1 hit paper · h-index 10

Impact in

Rheumatology top 0.5%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Musculoskeletal synovial abnormalities and treatments
Hematology top 2%
- Autoimmune and Inflammatory Disorders Research

Papers in

Rheumatology 6
- Rheumatoid Arthritis Research and Therapies 6
- Systemic Lupus Erythematosus Research 2
Emergency Medicine 3
- Emergency and Acute Care Studies 2

Co-authors: Duncan Porter W. Kincaid R. Vallance Alex D. McMahon Hilary A. Capell Peter Lock John Hunter T Blyth
Journals: Annals of Oncology (3 papers)Annals of the Rheumatic Diseases (2 papers)Lara D. Veeken (2 papers)BMJ Quality & Safety (1 paper)The Lancet (1 paper)
Partner nations: United Kingdom Australia United States

In The Last Decade

A. Stirling

13 papers receiving 1.5k citations

Hit Papers

align trajectories log scale

Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial 2004 · 1.0k citations

Peers

Countries citing papers authored by A. Stirling

Since Specialization

Citations

This map shows the geographic impact of A. Stirling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Stirling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Stirling more than expected).

Fields of papers citing papers by A. Stirling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Stirling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Stirling. The network helps show where A. Stirling may publish in the future.

Co-authors

The 25 scholars most cited alongside A. Stirling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Stirling Line = papers co-authored together A. Stirling links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work
1	580P TALAPRO-1: Talazoparib (TALA) monotherapy in metastatic castration-resistant prostate cancer (mCRPC) with DNA damage response alterations (DDRm) - Exploration of non-DDR mutational landscape and potential associations with antitumor activity Annals of Oncology ·桂川泰典, Johann S. de Bono, Alexander Laird, Philippe Barthélémy, R. Delva, Tanya B. Dorff, Marco Maruzzo, A. Stirling, J-P. Machiels, Herlinde Dumez, Vincent Renard, Julia F. Hopkins, Lee A. Albacker, Hsiang‐Cheng Chen, Cynthia G. Healy, Jijumon Chelliserry, Inge M. van Oort, Giorgio V. Scagliotti, Karim Fizazi	2021	1
2	581P Patient (pt) reported pain in men with metastatic castration-resistant prostate cancer (mCRPC) receiving talazoparib (TALA): TALAPRO-1 Annals of Oncology ·Fred Saad, Johann S. de Bono, Philippe Barthélémy, Tanya B. Dorff, Niven Mehra, Giorgio V. Scagliotti, A. Stirling, J-P. Machiels, Vincent Renard, Marco Maruzzo, Celestia S. Higano, Howard Gurney, Cynthia G. Healy, Helen Bhattacharyya, Bhakti Arondekar, Karl Peter D. Lagerlof, Karim Fizazi	2021	0
3	138P TALAPRO-1: Talazoparib (TALA) monotherapy in men with DNA damage response alterations (DDRalt) and metastatic castration-resistant prostate cancer (mCRPC): Exploration of DDRalt germline/somatic origin Annals of Oncology ·Niven Mehra, Karim Fizazi, Alexander Laird, Philippe Barthélémy, R. Delva, Tanya B. Dorff, Marco Maruzzo, A. Stirling, J-P. Machiels, Herlinde Dumez, Vincent Renard, Lee A. Albacker, Julia F. Hopkins, Hsiang‐Cheng Chen, Marielena Mata, Nicola Di Santo, Cynthia G. Healy, Inge M. van Oort, Consuelo Buttigliero, Johann S. de Bono	2020	2
4	Changes in Plasma Itaconate Elevation in Early Rheumatoid Arthritis Patients Elucidates Disease Activity Associated Macrophage Activation Metabolites ·Rónán Daly, Gavin Blackburn, Anne Chateau, Carl S. Goodyear, Manikhandan Mudaliar, Karl Burgess, A. Stirling, Duncan Porter, Iain B. McInnes, Michael P. Barrett, James Dale	2020	33
5	Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial Annals of the Rheumatic Diseases ·James Dale, A. Stirling, Ruiqi Zhang, David Purves, Jonathan H. Foley, Kelly Weiler, Philip G. Conaghan, Désirée van der Heijde, Alex McConnachie, Iain B. McInnes, Duncan Porter	2016	147
6	SAT0061 Comparison of Outcomes Between Studies of Intensive Treatment Strategies in Early RA from a Single Centre Over 20 Years Annals of the Rheumatic Diseases ·James Dale, A. Stirling, 王建昌, Nadeeshani Jayasinghe, Duncan Porter	2015	1
7	Introduction of a new observation chart and education programme is associated with higher rates of vital-sign ascertainment in hospital wards BMJ Quality & Safety ·Helen Cahill, Aaron Jones, Robert Herkes, K. Cook, A. Stirling, D., EURIDES,, A. I. Potselovkin, Sean Lal, B Bousseau, V. Humeniuk, David Gattas	2011	34
8	Viewing the taken-for-granted from under a different aspect: A video-based method in pursuit of patient safety International Journal of Multiple Research Approaches ·Rick Iedema, Eamon Merrick, Dorrilyn Rajbhandari, B Bousseau, A. Stirling, Robert Herkes	2009	46
9	Triple therapy in early active rheumatoid arthritis: A randomized, single‐blind, controlled trial comparing step‐up and parallel treatment strategies Arthritis & Rheumatism ·Nadeeshani Jayasinghe, H A Capell, A. Stirling, R. Vallance, W. Kincaid, Alex D. McMahon, Duncan Porter	2008	83
10	Effect of etanercept on serum amyloid A protein (SAA) levels in patients with AA amyloidosis complicating inflammatory arthritis Clinical Rheumatology ·W. J. Ball, A. Stirling, John Hunter	2008	17
11	Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial The Lancet ·王建昌, Hilary A. Capell, A. Stirling, Alex D. McMahon, Peter Lock, R. Vallance, Duncan Porter, W. Kincaid Hit paper breakdown →	2004	1029
12	Injection of the rheumatoid knee: does intra-articular methotrexate or rifampicin add to the benefits of triamcinolone hexacetonide? Lara D. Veeken ·T Blyth, A. Stirling, John H. Coote, David Land, John Hunter	1998	25
13	Low Intensity Laser and Phototherapy for Rheumatoid Arthritis Physiotherapy ·G C Goats, John Hunter, Antonio J. García Amate, A. Stirling	1996	25
14	PAIN RELIEF IN THE RHEUMATOID KNEE AFTER STEROID INJECTION A SINGLE-BLIND COMPARISON OF HYDROCORTISONE SUCCINATE, AND TRIAMCINOLONE ACETONIDE OR HEXACETONIDE Lara D. Veeken ·T Blyth, John Hunter, A. Stirling	1994	68

About A. Stirling

A. Stirling is a scholar working on Rheumatology, Emergency Medicine, Emergency Medical Services, Hematology and Oncology, having authored 14 papers that have together received 1.5k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (6 papers), Prostate Cancer Treatment and Research (3 papers), PARP inhibition in cancer therapy (3 papers), DNA Repair Mechanisms (2 papers), Emergency and Acute Care Studies (2 papers), Patient Safety and Medication Errors (2 papers), Systemic Lupus Erythematosus Research (2 papers) and Autoimmune and Inflammatory Disorders Research (2 papers). The work is most often cited by research in Rheumatology (1.3k citations), Hematology (556 citations), Genetics (238 citations), Pathology and Forensic Medicine (199 citations) and Immunology (219 citations). A. Stirling has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Duncan Porter, W. Kincaid, R. Vallance, Alex D. McMahon, Hilary A. Capell, Peter Lock, John Hunter, T Blyth, James Dale and Iain B. McInnes. Their work appears in journals such as Annals of Oncology, Annals of the Rheumatic Diseases, Lara D. Veeken, BMJ Quality & Safety and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact